Implantable sensor and system for in vivo measurement and control of fluid constituent levels
AssigneeAnimas Corporation
InventorKatherine D. Crothall
Life of this patent
Estimating the term…
Loading patent…
AssigneeAnimas Corporation
InventorKatherine D. Crothall
Estimating the term…
An in vivo implantable sensor obtains spectra of body fluid constituents and processes the spectra to determine the concentration of a constituent of the body fluid. The sensor includes an optical source and detector. The source emits light at a `plurality of different, discrete wavelengths, including at least one wavelength in the infrared region. The light interacts with the body fluid and is received at the detector. The light at the plurality of different wavelengths has a substantially collinear optical path through the fluid with respect to each other. When measuring fluid constituents in a blood vessel, such as blood glucose, the light at the plurality of different wavelengths is emitted in a substantially single period of time. The spectra is corrected for artifacts introduced from extraneous tissue in the optical path between the source and the detector. The sensor is fully implanted and is set in place to allow plural measurements to be taken at different time periods from a single in vivo position. The light source emits at at least three different wavelengths.
A method of determining a concentration of a constituent of body fluid in a mammal using in vivo spectroscopy, the method comprising the step of:
An implantable sensor adapted for determining a concentration of a chemical constituent of body fluid in a mammal using in vivo spectroscopy, the sensor comprising:
An infusion pump system for monitoring at least one chemical constituent of body fluid in a mammal and delivering medication to the mammal, the system comprising:
An implantable sensor adapted for determining a concentration of a chemical constituent of body fluid in a mammal using in vivo spectroscopy, the sensor comprising:
A method of determining a concentration of a constituent of body fluid in a mammal using in vivo spectroscopy, the method comprising the steps of:
A method of determining a concentration of blood glucose in a mammal using in vivo spectroscopy, the method comprising the steps of:
A method of determining a concentration of blood glucose in a mammal using in vivo spectroscopy, the method comprising the steps of:
A method of determining a concentration of a constituent of interstitial fluid or gel in a mammal using in vivo spectroscopy, the method comprising the steps of:
A method of determining a concentration of a constituent of body fluid in a mammal using in vivo spectroscopy, the method comprising the steps of:
An implantable sensor adapted for determining a concentration of a chemical constituent of body fluid in a mammal using in vivo spectroscopy, the sensor comprising:
An implantable sensor adapted for determining a concentration of a chemical constituent of body fluid in a mammal using in vivo spectroscopy, the sensor comprising:
An implantable sensor adapted for determining a concentration of a chemical constituent of body fluid in a mammal using in vivo spectroscopy, the sensor comprising:
An implantable sensor adapted for determining a concentration of blood glucose in a mammal using in vivo spectroscopy, the sensor comprising:
An implantable sensor adapted for determining a concentration of blood glucose in a mammal using in vivo spectroscopy, the sensor comprising:
An implantable sensor adapted for determining a concentration of a chemical constituent of interstitial fluid or gel in a mammal using in vivo spectroscopy, the sensor comprising:
A method of determining a concentration of a constituent of body fluid in a mammal using in vivo spectroscopy, the method comprising the steps of:
An implantable sensor adapted for determining a concentration of a chemical constituent of body fluid in a mammal using in vivo spectroscopy, the sensor comprising:
Dependencies are inferred from the claim text.